surbreak-19.png
Search

TripleBlind Receives Investment from Mayo Clinic, Expanding Current Collaboration

KANSAS CITY, Mo., April 27, 2021 (GLOBE NEWSWIRE) -- Today, TripleBlind announced that it expanded its collaboration with Mayo Clinic, which invested in a seed extension round, the only investor participating. TripleBlind recently announced that it raised $8.2 million in a significantly oversubscribed seed funding round. Mayo Clinic joins Accenture Ventures, Okta Ventures, NextGen Venture Partners, Operator Partners, Wavemaker Three-Sixty Health, AVG Basecamp Fund, Anorak Ventures, Quiet Capital, Clocktower Technology Ventures, Parity Responsible Technology Fund and Manresa Ventures as a TripleBlind investor.


CONTINUE READING

Recent Posts

See All

Tracking patients' treatment between doctors

It's a nightmare the very sick can find themselves in: Communicating their health history from one doctor to the next to get the critical care they need. It's been an extra burden during this already